Risiko
Årlig pris
0,25%
Informasjon om fondet
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
Bærekraft
SFDR bærekraftsmål
Artikkel 6
Morningstar-globus
🌐
🌐
🌐
🌐
🌐
Karbonrisiko
Lav
Fordeling
Største eierandeler
Eli Lilly and Co
16,0%
Johnson & Johnson
10,4%
AbbVie Inc
7,1%
UnitedHealth Group Inc
6,5%
Merck & Co Inc
5,6%
Amgen Inc
3,4%
Thermo Fisher Scientific Inc
3,2%
Gilead Sciences Inc
3,1%
Abbott Laboratories
2,8%
Intuitive Surgical Inc
2,8%
Helse
100,0%
Nord-Amerika
100,0%
USA
100,0%
Tilgjengelig på kontotype
Aksjesparekonto
Bedriftskonto
Detaljer
Pris
Dette koster fondet årlig
Aksjesparekonto:
0,35%
Prisdetaljer
Pris for fondet:
0,15%
Plattformavgift:
0,10%
(Eventuell rebalansering:
0,10%)
Avkastning
Avkastning pr. 28.05
Siste dag:
0,6%
Siste uke:
2,3%
Siste måned:
3,7%
Siste 6 måneder:
−11,8%
Hittil i år:
−10,8%
Siste år:
5,4%
Siste 3 år (per år):
0,9%
Siste 5 år (per år):
7,5%
Siste 10 år (per år):
10,5%
Nøkkelinfo
Morningstar-rating:
5
ISIN:
IE00B43HR379
Forvaltningskapital:
24 886 051 172 kr
Kategori:
Bransjefond, Helsevern
NAV/Kurs (28.05.2026):
112 kr
Aksjer:
99,7%
Kontanter:
0,3%
Obligasjoner:
0,0%
Annet:
0,0%
Startdato:
20.11.2015